Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP620772.RAicI54ekVRuJUg15Ifa96x6BB3PQb_qG80K0lXiUEPYg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP620772.RAicI54ekVRuJUg15Ifa96x6BB3PQb_qG80K0lXiUEPYg130_assertion type Assertion NP620772.RAicI54ekVRuJUg15Ifa96x6BB3PQb_qG80K0lXiUEPYg130_head.
- NP620772.RAicI54ekVRuJUg15Ifa96x6BB3PQb_qG80K0lXiUEPYg130_assertion description "[Our observations suggest that the subgroup of ovarian clear cell carcinomas harboring activated PIK3CA seems to have better prognosis possibly due to more indolent biological property compared to tumors without PIK3CA activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620772.RAicI54ekVRuJUg15Ifa96x6BB3PQb_qG80K0lXiUEPYg130_provenance.
- NP620772.RAicI54ekVRuJUg15Ifa96x6BB3PQb_qG80K0lXiUEPYg130_assertion evidence source_evidence_literature NP620772.RAicI54ekVRuJUg15Ifa96x6BB3PQb_qG80K0lXiUEPYg130_provenance.
- NP620772.RAicI54ekVRuJUg15Ifa96x6BB3PQb_qG80K0lXiUEPYg130_assertion SIO_000772 22955107 NP620772.RAicI54ekVRuJUg15Ifa96x6BB3PQb_qG80K0lXiUEPYg130_provenance.
- NP620772.RAicI54ekVRuJUg15Ifa96x6BB3PQb_qG80K0lXiUEPYg130_assertion wasDerivedFrom befree-20150227 NP620772.RAicI54ekVRuJUg15Ifa96x6BB3PQb_qG80K0lXiUEPYg130_provenance.
- NP620772.RAicI54ekVRuJUg15Ifa96x6BB3PQb_qG80K0lXiUEPYg130_assertion wasGeneratedBy ECO_0000203 NP620772.RAicI54ekVRuJUg15Ifa96x6BB3PQb_qG80K0lXiUEPYg130_provenance.